In a recent lecture for the Canadian Philosophical Association & the Canadian Society for the History and Philosophy of Science, I predicted that prediction markets would include betting on the success of repro-genetic interventions. This moves us closer to the unfortunate future I anticipate.
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients. n.pr/3RTTTRW